Cohort study evaluates leucovorin prescription rates in children with autism after governmental endorsement, indicating practice change.
This cohort study evaluates rates of leucovorin prescriptions for children with autism after a White House announcement promoting its use.
No takes yet. Share an insight, caveat, or question.
Rothman et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: